{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:02:57Z","timestamp":1788436977936,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3683-9","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T13:09:16Z","timestamp":1508850556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The relative risk of second primary cancers in Austria\u2019s western states: a retrospective cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Oliver","family":"Preyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Concin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Concin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi","family":"Oberaigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"3683_CR1","volume-title":"Multiple primaries internal report no. 00\/003","author":"International Association of Cancer Registries","year":"2000","unstructured":"International Association of Cancer Registries. Multiple primaries internal report no. 00\/003. Lyon: IARC; 2000."},{"key":"3683_CR2","volume-title":"SEER cancer statistics review, 1975\u20132013","year":"2016","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al., editors. SEER cancer statistics review, 1975\u20132013. Bethesda: National Cancer Institute; 2016. https:\/\/seer.cancer.gov\/csr\/1975_2013\/ based on November 2015 SEER data submission, posted to the SEER web site, April 2016"},{"key":"3683_CR3","first-page":"3373","volume":"54","author":"A Horri","year":"1994","unstructured":"Horri A, Han HJ, Shimada M, Yanagisawa A, Kato Y, Ohta H, et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res. 1994;54:3373\u20135. PMID: 8012952","journal-title":"Cancer Res"},{"key":"3683_CR4","volume-title":"New malignancies among cancer survivors: SEER cancer Registries,1973\u20132000","year":"2006","unstructured":"Curtis RE, Freedman DM, Ron E, LAG R, Hacker DG, Edwards BK, et al., editors. New malignancies among cancer survivors: SEER cancer Registries,1973\u20132000. Bethesda: National Cancer Institute. NIH Publ. No. 05\u20135302; 2006."},{"key":"3683_CR5","unstructured":"Statistik Austria, 2015; Available from: http:\/\/www.statistik.at\/web_de\/statistiken\/menschen_und_gesellschaft\/gesundheit\/krebserkrankungen\/krebspraevalenz\/index.html ."},{"key":"3683_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","volume":"15","author":"R De Angelis","year":"2014","unstructured":"De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. EUROCARE-5 working group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15:23\u201334. doi: 10.1016\/S1470-2045(13)70546-1 .","journal-title":"Lancet Oncol"},{"key":"3683_CR7","volume-title":"Cancer incidence in five continents, Vol. X (electronic version)","year":"2013","unstructured":"Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pi\u00f1eros M, et al., editors. Cancer incidence in five continents, Vol. X (electronic version). Lyon: International Agency for Research on Cancer; 2013. Available from: http:\/\/ci5.iarc.fr , accessed [date]. The printed version of this volume (IARC Scientific Publication No. 164) is available for download in PDF format at the IARC website http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/epi\/index.php ."},{"key":"3683_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1471-2407-14-272","volume":"14","author":"A Coyte","year":"2014","unstructured":"Coyte A, Morrison DS, McLoone P. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014;14:272\u201382. doi: 10.1186\/1471-2407-14-272 .","journal-title":"BMC Cancer"},{"key":"3683_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2407-11-83","volume":"11","author":"DR Youlden","year":"2011","unstructured":"Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study. BMC Cancer. 2011;11:83\u201394. doi: 10.1186\/1471-2407-11-83 .","journal-title":"BMC Cancer"},{"issue":"19","key":"3683_CR10","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/cncr.30164","volume":"122","author":"N Donin","year":"2016","unstructured":"Donin N, Filson C, Drakaki A, Tan H, Castillo A, Kwan L, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016 Oct;122(19):3075\u201386. doi: 10.1002\/cncr.30164 .","journal-title":"Cancer"},{"key":"3683_CR11","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1158\/1055-9965.EPI-14-0129","volume":"23","author":"SL Park","year":"2014","unstructured":"Park SL, Caberto CP, Lin Y, Goodloe RJ, Dumitrescu L, Love SA, et al. Association of cancer susceptibility variants with risk of multiple primary cancers: the population architecture using genomics and epidemiology study. Cancer Epidemiol Biomark Prev. 2014;23:2568\u201378. doi: 10.1158\/1055-9965.EPI-14-0129 .","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3683_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1160\/ME0299","volume":"46","author":"W Oberaigner","year":"2007","unstructured":"Oberaigner W. Errors in survival rates caused by routinely used deterministic record linkage methods. Methods Inf Med. 2007;46:420\u20134. PMID: 17694235","journal-title":"Methods Inf Med"},{"key":"3683_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0038-1634018","volume":"44","author":"W Oberaigner","year":"2005","unstructured":"Oberaigner W, St\u00fchlinger W. Record linkage in the cancer registry of Tyrol. Methods Inf Med. 2005;44:626\u201330. PMID: 16400370","journal-title":"Methods Inf Med"},{"key":"3683_CR14","first-page":"104","volume":"6","author":"IARC\/ENCR\/IACR Working Group","year":"2005","unstructured":"IARC\/ENCR\/IACR Working Group. International rules for multiple primary cancers. Asian Pacific J Cancer Prev. 2005;6:104\u20136. PMID: 15801152","journal-title":"Asian Pacific J Cancer Prev"},{"key":"3683_CR15","series-title":"Check and conversion programs for cancer registries. (IARC\/IACR tools for cancer registries)","volume-title":"IARC tool for transforming ICD-O to Icd10","author":"J Ferlay","year":"2005","unstructured":"Ferlay J, Burkhard C, Whelan S, Parkin DM. IARC tool for transforming ICD-O to Icd10, Check and conversion programs for cancer registries. (IARC\/IACR tools for cancer registries). Lyon: IARC Technical Report No. 42; 2005."},{"key":"3683_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00001648-200301000-00026","volume":"14","author":"P Sasieni","year":"2003","unstructured":"Sasieni P. On the expected number of cancer deaths during follow-up of an initially cancer-free cohort. Epidemiology. 2003;14:108\u201310. PMID: 12500058","journal-title":"Epidemiology"},{"key":"3683_CR17","unstructured":"PDQ Cancer Genetics Editorial Board. Genetics of prostate cancer (PDQ\u00ae): health professional version. Bethesda: PDQ Cancer Information Summaries. [Internet] (MD): National Cancer Institute (US); 10 Feb 2002-2017. Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65784\/ . PubMed PMID: 26389227"},{"key":"3683_CR18","unstructured":"Curtis RE, Freedman DM, Ron E, LAG R, Hacker DG, Edwards BK, et al. New malignancies among cancer survivors: SEER cancer registries, 1973\u20132000. Bethesda: NIH Publ. No. 05\u20135302."},{"key":"3683_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.1317","volume":"93","author":"HK Dong","year":"2001","unstructured":"Dong HK. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer. 2001;93:155\u201361. PMID: 11410860","journal-title":"Int J Cancer"},{"key":"3683_CR20","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0959-8049(01)00314-8","volume":"37","author":"E Crocetti","year":"2001","unstructured":"Crocetti E, Buiatti E, Falini P. Multiple primary cancer incidence in Italy. Eur J Cancer. 2001;37:2449\u201356. PMID: 11720842","journal-title":"Eur J Cancer"},{"key":"3683_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cncr.29685","volume":"122","author":"JS Lee","year":"2016","unstructured":"Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RL. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122:116\u201323. doi: 10.1002\/cncr.29685 .","journal-title":"Cancer"},{"key":"3683_CR22","doi-asserted-by":"crossref","unstructured":"Schottenfeld D. Multiple primary cancers. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford University Press. p. 1370\u201387.","DOI":"10.1093\/acprof:oso\/9780195149616.003.0066"},{"key":"3683_CR23","first-page":"411","volume":"68","author":"HH Storm","year":"1985","unstructured":"Storm HH, Jenson OM, Ewertz M, Lynge E, Olsen JH, Schou G, et al. Summary: multiple primary cancers in Denmark, 1943-1980. Natl Cancer Inst Monogr. 1985;68:411\u201330. PMID: 4088312","journal-title":"Natl Cancer Inst Monogr"},{"key":"3683_CR24","unstructured":"Van Leeuwen FE, Travis LB. Second cancers. In: VT DV, Hellman S, Rosenberg SA, editors. Cancer: Prinicipes and practice of oncology. 6th ed. Philadelphia: Lippincott, Williams & Wilkins. p. 2939\u201364."},{"key":"3683_CR25","doi-asserted-by":"publisher","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","volume":"6","author":"G Danaei","year":"2009","unstructured":"Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058. doi: 10.1371\/journal.pmed.1000058 .","journal-title":"PLoS Med"},{"key":"3683_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5993\/AJHB.27.3.6","volume":"27","author":"CM Blanchard","year":"2003","unstructured":"Blanchard CM, Denniston MM, Baker F, Ainsworth SR, Courneya KS, Hann DM, et al. Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav. 2003;27:246\u201356. PMID: 12751621","journal-title":"Am J Health Behav"},{"key":"3683_CR27","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/cncr.29841","volume":"122","author":"SC Kamran","year":"2016","unstructured":"Kamran SC, Berrington de Gonzales A, Ng A, Haas-Kogan D, Viswanathan AN. Therapeutic radiation and the potential risk of second malignancies. Cancer. 2016;122:1809\u201321. doi: 10.1002\/cncr.29841 .","journal-title":"Cancer"},{"key":"3683_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.radonc.2011.09.013","volume":"105","author":"D Bartkowiak","year":"2012","unstructured":"Bartkowiak D, Humble N, Suhr P, Hagg J, Mair K, Polivka B, et al. Second cancer after radiotherapy, 1981-2007. Radiother Oncol. 2012;105:122\u20136. doi: 10.1016\/j.radonc.2011.09.013 .","journal-title":"Radiother Oncol"},{"key":"3683_CR29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"LB Travis","year":"2003","unstructured":"Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Clarke EA, et al. Breast cancer following radiotherapy and chemotherapy for Hodgkin\u2019s disease. JAMA. 2003;290:465\u201375. PMID: 12876089","journal-title":"JAMA"},{"key":"3683_CR30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","volume":"95","author":"FE Van Leeuwen","year":"2003","unstructured":"Van Leeuwen FE, Klokman WJ, Stovall M, Dahler E, van\u2019t Veer MB, Noordijk EM, et al. The role of radiation dose, chemotherapy, treatment-related ovarian ablation, and other risk factors in breast cancer following Hodgkin\u2019s disease. J Natl Cancer Inst. 2003;95:971\u201380. PMID: 12837833","journal-title":"J Natl Cancer Inst"},{"key":"3683_CR31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","volume":"94","author":"LB Travis","year":"2002","unstructured":"Travis LB, Gospodarowicz M, Curtis RE, Clarke A, Anderson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin\u2019s disease. J Natl Cancer Inst. 2002;94:182\u201392. PMID: 11830608","journal-title":"J Natl Cancer Inst"},{"key":"3683_CR32","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199206253262605","volume":"326","author":"RE Curtis","year":"1992","unstructured":"Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med. 1992;326:1745\u201351. PMID: 1594016","journal-title":"N Engl J Med"},{"key":"3683_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","volume":"121","author":"T Grantzau","year":"2016","unstructured":"Grantzau T, Overgaard J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients. Radiother Oncol. 2016;121:402\u201313. doi: 10.1016\/j.radonc.2016.08.017 . PubMed PMID: 27639892","journal-title":"Radiother Oncol"},{"key":"3683_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00129804-200311000-00004","volume":"26","author":"T Vega-Stromberg","year":"2003","unstructured":"Vega-Stromberg T. Chemotherapy-induced secondary malignancies. J Infus Nurs. 2003;26:353\u201361. PMID: 14624175","journal-title":"J Infus Nurs"},{"key":"3683_CR35","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1056\/NEJMe048300","volume":"351","author":"RC Bast Jr","year":"2004","unstructured":"Bast RC Jr, Hortobagyi GN. Individualized care for patients with cancer - a work in progress. N Engl J Med. 2004;351:2865\u20137. PMID: 15591336","journal-title":"N Engl J Med"},{"key":"3683_CR36","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1056\/NEJMp1409841","volume":"371","author":"HS Ahn","year":"2014","unstructured":"Ahn HS, Kim HJ, Welch HG. Korea\u2019s thyroid-cancer \u201cepidemic\u201d--screening and overdiagnosis. N Engl J Med. 2014;371:1765\u20137. doi: 10.1056\/NEJMp1409841 . PMID: 25372084","journal-title":"N Engl J Med"},{"key":"3683_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"AB Mariotto","year":"2011","unstructured":"Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117\u201328. doi: 10.1093\/jnci\/djq495 .","journal-title":"J Natl Cancer Inst"},{"key":"3683_CR38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0140-6736(05)67725-2","volume":"366","author":"G Danaei","year":"2005","unstructured":"Danaei G, Van der Hoorn S, Lopez AD, Murray CJL, Ezzati M, the Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784\u201393. PMID: 16298215","journal-title":"Lancet"},{"key":"3683_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00508-014-0596-3","volume":"126","author":"W Oberaigner","year":"2014","unstructured":"Oberaigner W, Geiger-Gritsch S. Prediction of cancer incidence in Tyrol\/Austria for year of diagnosis 2020. Wien Klin Wochenschr. 2014;126:642\u20139. doi: 10.1007\/s00508-014-0596-3 . PubMed PMID: 25193482","journal-title":"Wien Klin Wochenschr"},{"key":"3683_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.urol.2007.09.029","volume":"179","author":"SM Gilbert","year":"2008","unstructured":"Gilbert SM, Miller DC, Hollenbeck BK, Montie JE, Wei JT. Cancer survivorship-challenges and changing paradigms. J Urol. 2008;179:431\u20138. doi: 10.1016\/j.urol.2007.09.029 .","journal-title":"J Urol"},{"key":"3683_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JOP.2013.001322","volume":"10","author":"KM Fenn","year":"2014","unstructured":"Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors\u2019 quality of life. J Oncol financial burden of cancer on survivors\u2019 quality of life. J Oncol Pract. 2014;10:332\u20138. doi: 10.1200\/JOP.2013.001322 .","journal-title":"J Oncol Pract"},{"key":"3683_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","volume":"383","author":"P Vineis","year":"2014","unstructured":"Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383:549\u201357. doi: 10.1016\/S0140-6736(13)62224-2 .","journal-title":"Lancet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3683-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T02:46:55Z","timestamp":1570243615000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3683-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3683-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"article-number":"699"}}